AI-generated drug begins clinical trials as historic first
Insilico Medicine created the world’s first fully AI-generated drug, and it will launch clinical trials with human patients next week. The Hong Kong-based biotech firm calls it INS018_055, which would treat idiopathic pulmonary fibrosis. CNBC says it affects roughly 100,000 US citizens and can lead to death in two to five years. Many people use […]
The post AI-generated drug begins clinical trials as historic first appeared first on Inquirer Technology.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.